Subtle%20Shapes%20Transparent_edited.png

INSIGHTS

Insights

Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.

Team Archbow

2 days ago

Case Study: Fresh Approach to HUB Communications Drives 20% User Growth

Team Archbow

Sep 12

Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be

Kevin Cast

Sep 8

Key Takeaways from the Health Systems & Pharma Partnering Summit 2023

Team Archbow

Sep 6

Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services

Team Archbow

Aug 31

Five Takeaways from Medicare's 10 Drugs Up for Price Negotiation

Team Archbow

Aug 29

Pharma Has a Pull-Through Problem; The Answer is Data

Team Archbow

Aug 15

Are Alternative Distribution Models a Viable Option for Pharma?

Team Archbow

Jul 6

How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data

Team Archbow

Jun 20

Take the Pain out of Conversations About Coverage

Valuate Health Consultancy

Jun 6

Market Access POV: ICER and Specialty Drug Coverage

Shannon Hybner

May 23

Good vs. Excellent: How to Maximize Your 3PL Partnership

Team Archbow

May 17

Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit

Team Archbow

May 9

How Manufacturers Can Optimize Hub Services

Team Archbow

Apr 25

Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies

Team Archbow

Feb 6

INSIGHTS

Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.

Case Study: Fresh Approach to HUB Communications Drives 20% User Growth

Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be

Key Takeaways from the Health Systems & Pharma Partnering Summit 2023

Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services

Five Takeaways from Medicare's 10 Drugs Up for Price Negotiation

Pharma Has a Pull-Through Problem; The Answer is Data

Are Alternative Distribution Models a Viable Option for Pharma?

How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data

Take the Pain out of Conversations About Coverage

Market Access POV: ICER and Specialty Drug Coverage

Good vs. Excellent: How to Maximize Your 3PL Partnership

Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit

How Manufacturers Can Optimize Hub Services

Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies

Essential Takeaways from the 2023 ECRM Conference